BIOCRYST PHARMACEUTICALS, INC. Amortization of Debt Issuance Costs
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Amortization of Debt Issuance Costs of $898.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2023-05-08
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for the quarter ending 2023-03-31 was $898.00K, a 437.72% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for the quarter ending 2022-03-31 was $167.00K.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for the quarter ending 2020-12-31 was $1.37M, a 299.71% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for the quarter ending 2020-09-30 was $381.00K, a 11.73% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for fiscal 2020 was $2.43M, a 89.98% increase from fiscal 2019.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for fiscal 2019 was $1.28M, a 44.41% increase from fiscal 2018.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for fiscal 2018 was $885.00K, a 1.03% increase from fiscal 2017.
- BIOCRYST PHARMACEUTICALS, INC. amortization of debt issuance costs for fiscal 2017 was $876.00K, a 56.99% increase from fiscal 2016.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-03-31 | $898.00K 10-Q · filed 2023-05-08 | |||
| 2022-09-30 | $597.00K 10-Q · filed 2022-11-04 | |||
| 2022-03-31 | $167.00K 10-Q · filed 2023-05-08 | |||
| 2021-09-30 | $369.00K 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.75M derived: sum of 2 quarters · filed 2021-03-01 | $2.09M derived: sum of 3 quarters · filed 2021-03-01 | $2.43M 10-K · filed 2021-03-01 |
| 2020-09-30 | $381.00K 10-Q · filed 2020-11-06 | $722.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.06M 10-Q · filed 2020-11-06 | $1.41M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $341.00K 10-Q · filed 2020-08-07 | $681.00K 10-Q · filed 2020-08-07 | $1.02M derived: sum of 3 quarters · filed 2021-03-01 | $1.36M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $341.00K 10-Q · filed 2020-05-11 | $683.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.02M derived: sum of 3 quarters · filed 2021-03-01 | $1.36M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $683.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.02M derived: sum of 3 quarters · filed 2021-03-01 | $1.28M 10-K · filed 2021-03-01 |
| 2019-09-30 | $341.00K 10-Q · filed 2020-11-06 | $682.00K derived: sum of 2 quarters · filed 2020-11-06 | $936.00K 10-Q · filed 2020-11-06 | $1.15M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $341.00K 10-Q · filed 2020-08-07 | $596.00K 10-Q · filed 2020-08-07 | $805.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $255.00K 10-Q · filed 2020-05-11 | $464.00K derived: sum of 2 quarters · filed 2021-03-01 | $686.00K derived: sum of 3 quarters · filed 2021-03-01 | $909.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $431.00K derived: sum of 2 quarters · filed 2021-03-01 | $654.00K derived: sum of 3 quarters · filed 2021-03-01 | $885.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $222.00K 10-Q · filed 2019-11-08 | $445.00K derived: sum of 2 quarters · filed 2019-11-08 | $676.00K 10-Q · filed 2019-11-08 | $895.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $223.00K 10-Q · filed 2019-08-08 | $455.00K 10-Q · filed 2019-08-08 | $673.00K derived: sum of 3 quarters · filed 2020-03-13 | $892.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $232.00K 10-Q · filed 2019-05-09 | $450.00K derived: sum of 2 quarters · filed 2020-03-13 | $669.00K derived: sum of 3 quarters · filed 2020-03-13 | $889.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $437.00K derived: sum of 2 quarters · filed 2020-03-13 | $657.00K derived: sum of 3 quarters · filed 2020-03-13 | $876.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $219.00K 10-Q · filed 2018-11-08 | $439.00K derived: sum of 2 quarters · filed 2018-11-08 | $658.00K 10-Q · filed 2018-11-08 | $882.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $220.00K 10-Q · filed 2018-08-09 | $439.00K 10-Q · filed 2018-08-09 | $663.00K derived: sum of 3 quarters · filed 2019-03-14 | $779.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $220.00K 10-Q · filed 2018-05-09 | $443.00K derived: sum of 2 quarters · filed 2019-03-14 | $559.00K derived: sum of 3 quarters · filed 2019-03-14 | $669.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $339.00K derived: sum of 2 quarters · filed 2019-03-14 | $449.00K derived: sum of 3 quarters · filed 2019-03-14 | $558.00K 10-K · filed 2019-03-14 |
| 2016-09-30 | $116.00K 10-Q · filed 2017-11-08 | $226.00K derived: sum of 2 quarters · filed 2017-11-08 | $335.00K 10-Q · filed 2017-11-08 | $446.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $110.00K 10-Q · filed 2017-08-08 | $220.00K 10-Q · filed 2017-08-08 | $330.00K derived: sum of 3 quarters · filed 2018-03-12 | $440.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $110.00K 10-Q · filed 2017-05-08 | $220.00K derived: sum of 2 quarters · filed 2018-03-12 | $330.00K derived: sum of 3 quarters · filed 2018-03-12 | $440.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $220.00K derived: sum of 2 quarters · filed 2018-03-12 | $330.00K derived: sum of 3 quarters · filed 2018-03-12 | $439.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $110.00K 10-Q · filed 2016-11-08 | $220.00K derived: sum of 2 quarters · filed 2016-11-08 | $329.00K 10-Q · filed 2016-11-08 | $440.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $110.00K 10-Q · filed 2016-08-08 | $220.00K 10-Q · filed 2016-08-08 | $330.00K derived: sum of 3 quarters · filed 2017-02-27 | $440.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $110.00K 10-Q · filed 2016-05-09 | $220.00K derived: sum of 2 quarters · filed 2017-02-27 | $330.00K derived: sum of 3 quarters · filed 2017-02-27 | $440.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $220.00K derived: sum of 2 quarters · filed 2017-02-27 | $330.00K derived: sum of 3 quarters · filed 2017-02-27 | $439.00K 10-K · filed 2017-02-27 |
| 2014-09-30 | $110.00K 10-Q · filed 2015-11-06 | $220.00K derived: sum of 2 quarters · filed 2015-11-06 | $329.00K 10-Q · filed 2015-11-06 | $440.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $110.00K 10-Q · filed 2015-08-07 | $220.00K 10-Q · filed 2015-08-07 | $330.00K derived: sum of 3 quarters · filed 2016-02-26 | $440.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $110.00K 10-Q · filed 2015-05-08 | $220.00K derived: sum of 2 quarters · filed 2016-02-26 | $330.00K derived: sum of 3 quarters · filed 2016-02-26 | $440.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $220.00K derived: sum of 2 quarters · filed 2016-02-26 | $330.00K derived: sum of 3 quarters · filed 2016-02-26 | $439.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | $110.00K 10-Q · filed 2014-11-07 | $220.00K derived: sum of 2 quarters · filed 2014-11-07 | $329.00K 10-Q · filed 2014-11-07 | $440.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $110.00K 10-Q · filed 2014-08-08 | $220.00K 10-Q · filed 2014-08-08 | $330.00K derived: sum of 3 quarters · filed 2015-03-02 | $440.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $110.00K 10-Q · filed 2014-05-09 | $220.00K derived: sum of 2 quarters · filed 2015-03-02 | $330.00K derived: sum of 3 quarters · filed 2015-03-02 | $440.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $220.00K derived: sum of 2 quarters · filed 2015-03-02 | $330.00K derived: sum of 3 quarters · filed 2015-03-02 | $439.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | $110.00K 10-Q · filed 2013-11-08 | $220.00K derived: sum of 2 quarters · filed 2013-11-08 | $329.00K 10-Q · filed 2013-11-08 | $440.00K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $110.00K 10-Q · filed 2013-08-08 | $220.00K 10-Q · filed 2013-08-08 | $330.00K derived: sum of 3 quarters · filed 2014-03-10 | $439.00K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $110.00K 10-Q · filed 2013-05-09 | $220.00K derived: sum of 2 quarters · filed 2014-03-10 | $329.00K derived: sum of 3 quarters · filed 2014-03-10 | $435.00K derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $219.00K derived: sum of 2 quarters · filed 2014-03-10 | $325.00K derived: sum of 3 quarters · filed 2014-03-10 | $356.00K 10-K · filed 2014-03-10 |
| 2011-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $215.00K derived: sum of 2 quarters · filed 2012-11-08 | $246.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $137.00K 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $31.00K 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |